NCT05494853View on ClinicalTrials.gov

Novel Biomarker Assay for Biomarker Assay for HCC Detection

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2025

Conditions

Hepato-cellular Carcinoma

Sponsors

Lead Sponsor

Genetron Health

All Listed Sponsors

collaborator

"Piedmont Transplant Institute. 1968 Peachtree Road, NW

UNKNOWN

lead

Genetron Health

INDUSTRY

NCT05494853 - Novel Biomarker Assay for Biomarker Assay for HCC Detection | Biotech Hunter | Biotech Hunter